← All trials
NCT06727734
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2024
- Primary completion
- Sep 30, 2027
- Completion date
- Oct 31, 2027
- First posted
- Dec 11, 2024
- Last posted
- Dec 11, 2024
- Enrollment
- 980
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The University of Hong KongLead sponsor
- The University of Hong KongOfficial
- The Family Planning Association of Hong KongCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.